Clinical Trials & Research Studies

A Phase 1 Randomized Placebo-controlled Clinical Trial of the Safety, Pharmacokinetics, and Antiviral Activity of PGDM 1400 and PGT 121 Monoclonal Antibodies in HIV-infected Adults


Brief description of study

This is a Phase 1 study to evaluate the safety, tolerability, pharmacokinetics and anti-viral efficacy of the PGDM1400 and PGT121 mAbs for HIV prevention and therapy.

Clinical Study Identifier: NCT03205917

Contact research investigator to learn more about this study by filling out the form below.


To: Research Study Investigator
Subject: I am interested in participating in your Research Study
Dear Investigator,
I'm interested in learning more about and participating in your research study named: A Phase 1 Randomized Placebo-controlled Clinical Trial of the Safety, Pharmacokinetics, and Antiviral Activity of PGDM 1400 and PGT 121 Monoclonal Antibodies in HIV-infected Adults
I am hoping to hear back from you and discuss details of the study

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.